179 related articles for article (PubMed ID: 25907632)
21. Parkin mutations and early-onset parkinsonism in a Taiwanese cohort.
Wu RM; Bounds R; Lincoln S; Hulihan M; Lin CH; Hwu WL; Chen J; Gwinn-Hardy K; Farrer M
Arch Neurol; 2005 Jan; 62(1):82-7. PubMed ID: 15642853
[TBL] [Abstract][Full Text] [Related]
22. Gene symbol: PARK2. Disease: Parkinsonism, juvenile, autosomal recessive.
Lesage S; Lohmann E; Tison F; Durif F; Dürr A; Brice A
Hum Genet; 2008 Feb; 123(1):114. PubMed ID: 18386383
[No Abstract] [Full Text] [Related]
23. [Genotype and phenotype analyses of three families with autosomal recessive juvenile parkinsonism].
Guo JF; Tang BS; Zhang YH; Liu HJ; Yan XX; Chen T; Shen L; Jiang H; Xia K; Cai F; Pan Q
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Feb; 23(1):70-3. PubMed ID: 16456791
[TBL] [Abstract][Full Text] [Related]
24. Successful twin pregnancy in a patient with parkin-associated autosomal recessive juvenile parkinsonism.
Serikawa T; Shimohata T; Akashi M; Yokoseki A; Tsuchiya M; Hasegawa A; Haino K; Koike R; Takakuwa K; Tanaka K; Tanaka K; Nishizawa M
BMC Neurol; 2011 Jun; 11():72. PubMed ID: 21682904
[TBL] [Abstract][Full Text] [Related]
25. A Peruvian family with a novel PARK2 mutation: Clinical and pathological characteristics.
Cornejo-Olivas MR; Torres L; Mata IF; Mazzetti P; Rivas D; Cosentino C; Inca-Martinez M; Cuba JM; Zabetian CP; Leverenz JB
Parkinsonism Relat Disord; 2015 May; 21(5):444-8. PubMed ID: 25817512
[TBL] [Abstract][Full Text] [Related]
26. Association between early-onset Parkinson's disease and mutations in the parkin gene.
Lücking CB; Dürr A; Bonifati V; Vaughan J; De Michele G; Gasser T; Harhangi BS; Meco G; Denèfle P; Wood NW; Agid Y; Brice A; ;
N Engl J Med; 2000 May; 342(21):1560-7. PubMed ID: 10824074
[TBL] [Abstract][Full Text] [Related]
27. Autosomal recessive early onset parkinsonism is linked to three loci: PARK2, PARK6, and PARK7.
Bonifati V; Dekker MC; Vanacore N; Fabbrini G; Squitieri F; Marconi R; Antonini A; Brustenghi P; Dalla Libera A; De Mari M; Stocchi F; Montagna P; Gallai V; Rizzu P; van Swieten JC; Oostra B; van Duijn CM; Meco G; Heutink P;
Neurol Sci; 2002 Sep; 23 Suppl 2():S59-60. PubMed ID: 12548343
[TBL] [Abstract][Full Text] [Related]
28. Alternative splicing generates different parkin protein isoforms: evidences in human, rat, and mouse brain.
Scuderi S; La Cognata V; Drago F; Cavallaro S; D'Agata V
Biomed Res Int; 2014; 2014():690796. PubMed ID: 25136611
[TBL] [Abstract][Full Text] [Related]
29. Molecular findings in familial Parkinson disease in Spain.
Hoenicka J; Vidal L; Morales B; Ampuero I; Jiménez-Jiménez FJ; Berciano J; del Ser T; Jiménez A; Ruíz PG; de Yébenes JG
Arch Neurol; 2002 Jun; 59(6):966-70. PubMed ID: 12056932
[TBL] [Abstract][Full Text] [Related]
30. Analysis of Leucine-rich repeat kinase 2 (LRRK2) and Parkinson protein 2 (parkin, PARK2) genes mutations in Slovak Parkinson disease patients.
Bognar C; Baldovic M; Benetin J; Kadasi L; Zatkova A
Gen Physiol Biophys; 2013 Mar; 32(1):55-66. PubMed ID: 23531835
[TBL] [Abstract][Full Text] [Related]
31. Parkin truncating variants result in a loss-of-function phenotype.
Santos M; Morais S; Pereira C; Sequeiros J; Alonso I
Sci Rep; 2019 Nov; 9(1):16150. PubMed ID: 31695088
[TBL] [Abstract][Full Text] [Related]
32. Parkin mutations are frequent in patients with isolated early-onset parkinsonism.
Periquet M; Latouche M; Lohmann E; Rawal N; De Michele G; Ricard S; Teive H; Fraix V; Vidailhet M; Nicholl D; Barone P; Wood NW; Raskin S; Deleuze JF; Agid Y; Dürr A; Brice A; ;
Brain; 2003 Jun; 126(Pt 6):1271-8. PubMed ID: 12764050
[TBL] [Abstract][Full Text] [Related]
33. Metabolomics-based identification of metabolic alterations in PARK2.
Okuzumi A; Hatano T; Ueno SI; Ogawa T; Saiki S; Mori A; Koinuma T; Oji Y; Ishikawa KI; Fujimaki M; Sato S; Ramamoorthy S; Mohney RP; Hattori N
Ann Clin Transl Neurol; 2019 Mar; 6(3):525-536. PubMed ID: 30911576
[TBL] [Abstract][Full Text] [Related]
34. Biallelic Parkin (PARK2) mutations can cause a bvFTD phenotype without clinically relevant parkinsonism.
Zimmermann M; Wilke C; Schulte C; Hoffmann J; Klopfer J; Reimold M; Brockmann K; Synofzik M
Parkinsonism Relat Disord; 2018 Oct; 55():145-147. PubMed ID: 29910155
[No Abstract] [Full Text] [Related]
35. Low frequency of the PARK2 gene mutations in Polish patients with the early-onset form of Parkinson disease.
Koziorowski D; Hoffman-Zacharska D; Sławek J; Szirkowiec W; Janik P; Bal J; Friedman A
Parkinsonism Relat Disord; 2010 Feb; 16(2):136-8. PubMed ID: 19628420
[TBL] [Abstract][Full Text] [Related]
36. A molecular explanation for the recessive nature of parkin-linked Parkinson's disease.
Spratt DE; Martinez-Torres RJ; Noh YJ; Mercier P; Manczyk N; Barber KR; Aguirre JD; Burchell L; Purkiss A; Walden H; Shaw GS
Nat Commun; 2013; 4():1983. PubMed ID: 23770917
[TBL] [Abstract][Full Text] [Related]
37. Analysis of eighteen deletion breakpoints in the parkin gene.
Asakawa S; Hattori N; Shimizu A; Shimizu Y; Minoshima S; Mizuno Y; Shimizu N
Biochem Biophys Res Commun; 2009 Nov; 389(1):181-6. PubMed ID: 19715670
[TBL] [Abstract][Full Text] [Related]
38. Detection of Parkin (PARK2) and DJ1 (PARK7) mutations in early-onset Parkinson disease: Parkin mutation frequency depends on ethnic origin of patients.
Djarmati A; Hedrich K; Svetel M; Schäfer N; Juric V; Vukosavic S; Hering R; Riess O; Romac S; Klein C; Kostic V
Hum Mutat; 2004 May; 23(5):525. PubMed ID: 15108293
[TBL] [Abstract][Full Text] [Related]
39. Sensory neuropathy in autosomal recessive juvenile parkinsonism (PARK2).
Okuma Y; Hattori N; Mizuno Y
Parkinsonism Relat Disord; 2003 Jun; 9(5):313-4. PubMed ID: 12781600
[TBL] [Abstract][Full Text] [Related]
40. Parkin mutation dosage and the phenomenon of anticipation: a molecular genetic study of familial parkinsonism.
Poorkaj P; Moses L; Montimurro JS; Nutt JG; Schellenberg GD; Payami H
BMC Neurol; 2005 Feb; 5(1):4. PubMed ID: 15725358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
